Benefits of AstraZeneca COVID-19 vaccine outweigh its risks
Pausing AstraZeneca vaccinations because of suspected links to deadly blood clots could allow COVID-19 to continue to spread, cause more deaths.
2021-04-27
(Press-News.org) WASHINGTON, April 27, 2021 -- The AstraZeneca COVID-19 vaccine is suspected of being linked to a small number of deep vein thrombosis (DVT) cases, which recently emerged within Europe as millions of people received vaccinations. This led several countries to suspend AstraZeneca injections and investigate the causal links to DVT.
Researchers within Europe teamed up to explore a hypothesis that pausing AstraZeneca vaccinations, even for a short duration, could cause additional deaths from the faster spread of COVID-19 within a population of susceptible individuals.
In Chaos, from AIP Publishing, researchers report using an epidemiological susceptible-exposed-infected-recovered (SEIR) model and statistical analysis of publicly available data to estimate excess deaths resulting from suspending AstraZeneca vaccinations and those potentially linked to DVT-adverse events in France and Italy.
They concluded the benefits of deploying the AstraZeneca vaccine greatly outweigh its associated risks, and relative benefits are wider in situations where the reproduction number is larger.
The SEIR model was discussed in a paper, published by Chaos, titled "Modeling the second wave of COVID-19 infections in France and Italy via a stochastic SEIR model." It was able to predict the magnitude and timing of the second wave of the disease in France and Italy.
"Despite its simplicity, the model is able to propagate uncertainties via adding interactivity as a source of randomness within the data," said Davide Faranda, from Laboratoire des Sciences du Climat et de l'Environnement and the London Mathematical Laboratory. "It mimics our ignorance of the exact parameters of the model due to testing capacities and evolving political and medical protocols."
Risk-benefit analysis is performed by using a methodology inspired by the Fermi estimates. The group compares the excess deaths due to temporal restriction of the AstraZeneca vaccine's deployment and excess deaths due to its possible side effects. Given the many uncertainties of possible side effects of the vaccine, they resorted to making worst-case scenario calculations to provide a robust upper bound to the related excess deaths.
"Our work shows suspending AstraZeneca vaccinations in France and Italy for three days without replacing it with another vaccine led to about 260 and 130 additional deaths, respectively," said Faranda. "The difference between the two countries' number of deaths is due to their different epidemiological situations and, in particular, to the higher basic reproduction number R0 measured in Italy with respect to France on March 15, 2021."
The group analyzed the case of resuming vaccinations at a doubled rate for the same number of days as the vaccination interruption.
"Excess deaths are still on the same order of magnitude as those observed by resuming vaccinations at the same rate as before the interruption but scaled down by a factor of two," said Faranda. "This is an evident outcome of nonlinear effects of epidemiological dynamics. Those who have not been vaccinated can contaminate other individuals before vaccination resumes."
Even if several countries have resumed or are about to resume AstraZeneca vaccinations, the researchers show the effect of the interruption is hard to counterbalance and will require doubling down on deployment of vaccines. For large countries where AstraZeneca vaccinations have resumed, confidence in vaccines has been reduced by a nonnegligible percentage.
"The analysis presented here was performed with a parsimonious but well posed and tested model, and we hope our results will be the starting point for more detailed, more advanced, and more mature investigations with sophisticated models and data collection exercises," said Faranda.
A first proof of the validity of their estimates is the report of seven DVT deaths per 18 million vaccinations within the U.K., a value that is in line with the group's work based on data available a few weeks ago and assuming a standard fatality rate of DVT from AstraZeneca vaccinations.
INFORMATION:
The article "Interrupting vaccination policies can greatly spread SARS-CoV-2 and enhance mortality from COVID-19 disease: The AstraZeneca case for France and Italy" is authored by Davide Faranda, Tommaso Alberti, Maxence Arutkin, Valerio Lembo, and Valerio Lucarini. It will appear in Chaos on April 27, 2021 (DOI: 10.1063/5.0050887). After that date, it can be accessed at https://aip.scitation.org/doi/10.1063/5.0050887.
ABOUT THE JOURNAL
Chaos is devoted to increasing the understanding of nonlinear phenomena in all areas of science and engineering and describing their manifestations in a manner comprehensible to researchers from a broad spectrum of disciplines. See https://aip.scitation.org/journal/cha.
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
2021-04-27
What The Study Did: Researchers examined whether younger age at onset of type 2 diabetes was associated with an increased risk of subsequent dementia.
Authors: Archana Singh-Manoux, Ph.D., of the Université de Paris, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jama.2021.4001)
Editor's Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, ...
2021-04-27
What The Study Did: Survey data were used to estimate the rate of human papillomavirus (HPV) vaccination among young adults ages 18 to 21 in the United States.
Authors: Michelle M. Chen, M.D., M.H.S., of the University of Michigan in Ann Arbor, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jama.2021.0725)
Editor's Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
Media advisory: The full study is linked ...
2021-04-27
What The Study Did: Researchers compared reasons for hospitalizations in children's hospitals in the United States before and during the COVID-19 pandemic.
Authors: Jay G. Berry, M.D., M.P.H., of Harvard Medical School in Boston, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jama.2021.4382)
Editor's Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# ...
2021-04-27
Bottom Line: The U.S. Preventive Services Task Force (USPSTF) reaffirms its earlier recommendation of screening for high blood pressure in adults 18 years or older with office blood pressure measurement and obtaining measurements outside of the clinical setting for confirming a diagnosis of high blood pressure before starting treatment. Hypertension affects approximately 45% of adults in the United States and is a major contributing risk factor for heart failure, heart attack, stroke and chronic kidney disease. The USPSTF routinely makes recommendations about the effectiveness of preventive care services and this recommendation reaffirms its 2015 statement.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jama.2021.4987)
Editor's ...
2021-04-27
What The Study Did: This analysis uses the World Health Organization pharmacovigilance database to explore the potential safety signal of facial paralysis after COVID-19 vaccination. When compared with other viral vaccines, mRNA COVID-19 vaccines did not display a signal of facial paralysis.
Authors: Charles Khouri, Pharm.D., of the University Grenoble Alpes and Grenoble Alpes University Hospital in Grenoble, France, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamainternmed.2021.2219)
Editor's Note: Please see the article for additional information, including ...
2021-04-27
Ambitious climate policies could help to reduce extreme poverty in developing countries. This is the result of a new study by scientists of the Potsdam Institute for Climate Impact Research (PIK) - a result that is in contrast to wide-spread assumptions that climate change mitigation comes with a trade-off for poverty reduction. To turn climate policies and poverty reduction into a win-win situation for planet and people, a progressive redistribution of emission pricing revenues and a fair international burden sharing are key.
"Climate policies safeguard people from climate change impacts like extreme weather risks or crop failures. Yet they can also imply increased energy and food prices," says Bjoern Soergel from PIK, lead-author of the study. "This could result in an additional ...
2021-04-27
A four-year effort has reduced the rate of cesarean sections for low-risk, first-time mothers in California, according to a study led by researchers at the Stanford University School of Medicine and the California Maternal Quality Care Collaborative.
The study will be published April 27 in the Journal of the American Medical Association.
Several coordinated initiatives to reduce C-sections took place across the state during the 2015-19 study period, including messaging to all hospitals from state agencies and health plans, annual public reporting of hospitals' C-section rates, and a quality improvement program targeting hospitals with the highest rates.
The study examined the collective effect of these projects, which have led California to become the first state in the country ...
2021-04-27
WASHINGTON, April 27, 2021 -- Despite the vast amount of water on Earth, most of it is nonpotable seawater. Freshwater accounts for only about 2.5% of the total, so much of the world experiences serious water shortages.
In AIP Advances, by AIP Publishing, scientists in China report the development of a highly efficient desalination device powered by solar energy. The device consists of a titanium-containing layer, TiNO, or titanium nitride oxide, capable of absorbing solar energy. The TiNO is deposited on a special type of paper and foam that allows the solar absorber ...
2021-04-27
WASHINGTON, April 27, 2021 -- Traffic accidents, tumor resections, and congenital diseases can cause significant trauma, which can lead to large bone deformations and/or bone loss. Although bone has some capacity to regenerate, large bone defects cannot be healed without major medical procedures.
In these situations, metallic implants are widely used, but the bioinertness of such implants poses a major challenge in bone tissue engineering. Bioinert metal implants lack bone integration, loosen over time, and may lead to adverse reactions around the area in which ...
2021-04-27
LA JOLLA--(April 27, 2021) Despite the prevalence of Alzheimer's, there are still no treatments, in part because it has been challenging to study how the disease develops. Now, scientists at the Salk Institute have uncovered new insights into what goes awry during Alzheimer's by growing neurons that resemble--more accurately than ever before--brain cells in older patients. And like patients themselves, the afflicted neurons appear to lose their cellular identity.
The findings, published April 27, 2021, in the journal Cell Stem Cell, showed that these brain cells are characterized by markers of stress as well as changes in which the cells become less specialized. ...
LAST 30 PRESS RELEASES:
[Press-News.org] Benefits of AstraZeneca COVID-19 vaccine outweigh its risks
Pausing AstraZeneca vaccinations because of suspected links to deadly blood clots could allow COVID-19 to continue to spread, cause more deaths.